The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Leo J. Hofland

Department of Internal Medicine

Division of Endocrinology

Erasmus MC

Rotterdam

Netherlands

[email]@erasmusmc.nl

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Internal Medicine, Division of Endocrinology, Erasmus MC, Rotterdam, Netherlands. 2003 - 2010

References

  1. Role of somatostatin receptors in normal and tumoral pituitary corticotropic cells. Hofland, L.J., Lamberts, S.W., Feelders, R.A. Neuroendocrinology (2010) [Pubmed]
  2. The somatostatin receptor subtype 5 in neuroendocrine tumours. van der Hoek, J., Lamberts, S.W., Hofland, L.J. Expert. Opin. Investig. Drugs (2010) [Pubmed]
  3. Pituitary tumours: the sst/D2 receptors as molecular targets. Hofland, L.J., Feelders, R.A., de Herder, W.W., Lamberts, S.W. Mol. Cell. Endocrinol. (2010) [Pubmed]
  4. Somatostatin and somatostatin receptors in Cushing's disease. Hofland, L.J. Mol. Cell. Endocrinol. (2008) [Pubmed]
  5. Induction of apoptosis with hybrids of Arg-Gly-Asp molecules and peptides and antimitotic effects of hybrids of cytostatic drugs and peptides. Hofland, L.J., Capello, A., Krenning, E.P., de Jong, M., van Hagen, M.P. J. Nucl. Med. (2005) [Pubmed]
  6. The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5. Hofland, L.J., van der Hoek, J., Feelders, R., van Aken, M.O., van Koetsveld, P.M., Waaijers, M., Sprij-Mooij, D., Bruns, C., Weckbecker, G., de Herder, W.W., Beckers, A., Lamberts, S.W. Eur. J. Endocrinol. (2005) [Pubmed]
  7. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects. Hofland, L.J., van der Hoek, J., Feelders, R., van der Lely, A.J., de Herder, W., Lamberts, S.W. J. Endocrinol. Invest. (2005) [Pubmed]
  8. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro. Hofland, L.J., van der Hoek, J., van Koetsveld, P.M., de Herder, W.W., Waaijers, M., Sprij-Mooij, D., Bruns, C., Weckbecker, G., Feelders, R., van der Lely, A.J., Beckers, A., Lamberts, S.W. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  9. Somatostatin receptors in pituitary function, diagnosis and therapy. Hofland, L.J., Lamberts, S.W. Front. Horm. Res (2004) [Pubmed]
  10. Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells. Dalm, V.A., van Hagen, P.M., van Koetsveld, P.M., Achilefu, S., Houtsmuller, A.B., Pols, D.H., van der Lely, A.J., Lamberts, S.W., Hofland, L.J. Am. J. Physiol. Endocrinol. Metab. (2003) [Pubmed]
  11. Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs. Hofland, L.J., Lamberts, S.W., van Hagen, P.M., Reubi, J.C., Schaeffer, J., Waaijers, M., van Koetsveld, P.M., Srinivasan, A., Krenning, E.P., Breeman, W.A. J. Nucl. Med. (2003) [Pubmed]
  12. Responsiveness to somatostatin analog treatment and potentials of novel somatostatin analog. Hofland, L.J. J. Endocrinol. Invest. (2003) [Pubmed]
 
WikiGenes - Universities